Valeo Pharma Inc. to announce that it has entered into an agreement with Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters pursuant to which the Underwriters has agreed to purchase
Valeo Pharma Inc., a Canadian pharmaceutical company, has appointed Frederic Fasano to the newly created position of President and Chief Operating Officer, to augment its senior leadership team and support expansion of Valeo's commercial activities.